share_log

MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes

MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes

MindMed:2022年第二季度財務和業務業績、管理和渠道變化
Benzinga Real-time News ·  2022/08/12 17:34
MindMed (NASDAQ:MNMD), which recently received a letter on behalf of one of its shareholders calling for a new business strategy and offering a solution, reported its earnings for the quarter ended June 30, 2022. And the next day, it announced the appointment of two independent directors to its board.
MindMed(納斯達克:MNMD),該公司最近收到了一封代表其一名股東的信,呼籲制定新的業務戰略並提供解決方案,該公司報告了截至2022年6月30日的季度收益。第二天,它宣佈了委任兩名獨立董事到它的董事會。
First, a quick financial report: 
首先,一個快速財務報告:
Total cash balance of $105.7 million, expected to be sufficient for the operating requirements beyond key development milestones until 2024. Net cash used in operating activities was $28.0 million within six months, compared to $21.2 million for the same period in 2021.  R&D expenses were $9.3 million within three months, compared...
現金餘額合計1.057億美元,預計將足以滿足2024年之前關鍵發展里程碑以外的業務需求。 ...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論